rediff.com

AstraZeneca Pharma India Q2 Profit Falls 27%

Share on:

By Rediff Money Desk, New Delhi   Nov 13, 2024 19:18

AstraZeneca Pharma India's net profit for Q2 FY25 declined 27% to Rs 38 crore, while revenue rose to Rs 408 crore. The company's shares closed 3.74% lower on the BSE.
New Delhi, Nov 13 (PTI) AstraZeneca Pharma India on Wednesday said its net profit declined by 27 per cent on-year to Rs 38 crore in the second quarter ended on September 30, 2024.

The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal.

Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period, the firm said in a regulatory filing.

Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

More »

Moneywiz Live!